Oxaliplatin

Oxaliplatin is the platinum-containing complex similar to cisplatin. This agent was recently approved for use as a second line therapy in metastatic colorectal cancer. Neurotoxicity is its dose limiting side effect and characterized by peripheral sensory neuropathy.


Adult Dose
Dose: 85 mg/sq. metre
Single Dose: 160 (156)
Frequency: As recommended.
Route: IV
Instructions: Every 2 weeks
Neonatal
Paedriatic
Characteristics
. It is of Synthetic origin. . The Molecular Weight of Oxaliplatin is 397.30.
Contraindications
Oxaliplatin is contraindicated in conditions like Peripheral neuropathy,Pregnancy,Breast feeding.
Effects
The severe or irreversible adverse effects of Oxaliplatin, which give rise to further complications include Bone marrow depression.The symptomatic adverse reactions produced by Oxaliplatin are more or less tolerable and if they become severe, they can be treated symptomatically, these include Alopecia, Ototoxicity, Myelosuppression, Nausea and vomiting, Gastrointestinal disturbances, Sensory peripheral neuropathy.
Indications
Oxaliplatin is primarily indicated in conditions like Cervical carcinoma, Cyclical benign breast disease, Germ cell tumors, Neurogenic bladder, Ovarian cancer, and can also be given in adjunctive therapy as an alternative drug of choice in Severe nausea, vomiting (acute attacks).
Interactions
Oxaliplatin is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAmikacin (Sulphate)You should inform your doctor before using this combination.Do not start or stop any medicine without doctor or pharmacist approval.Amphotericin BYou should inform your doctor before using this combination.Do not start or stop any medicine without doctor or pharmacist approval.Cyclosporin AYou should inform your doctor before using this combination.Do not start or stop any medicine without doctor or pharmacist approval.GentamicinYou should inform your doctor before using this combination.Do not start or stop any medicine without doctor or pharmacist approval.IbuprofenYou should inform your doctor before using this combination.Do not start or stop any medicine without doctor or pharmacist approval.TacrolimusYou should inform your doctor before using this combination.Do not start or stop any medicine without doctor or pharmacist approval.Vancomycin (HCl)You should inform your doctor before using this combination.Do not start or stop any medicine without doctor or pharmacist approval. These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Interfrence
Liver Function Test (LFT) Monitoring of hematologic profileMonitoring of ALT AND AST level
Risks
Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
Oxaliplatin in combination with fluorouracil and folinic acid, should be considered first-line treatment for advanced colorectal cancer only in patients with metastases which are confined to liver and which could be resected following treatment. Oxaliplatin causes mild renal impairment, so manufacturers advise avoid if creatinine clearance less than 30 ml/min.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.